nach oben

Erschienen in:

19.07.2019 | Preclinical study

Non-contrast MRI for breast screening: preliminary study on detectability of benign and malignant lesions in women with dense breasts

verfasst von: Yangyang Bu, Jun Xia, Bobby Joseph, Xianjing Zhao, Maosheng Xu, Yingxing Yu, Shouliang Qi, Kamran A. Shah, Shiwei Wang, Jiani Hu

Erschienen in: Breast Cancer Research and Treatment | Ausgabe 3/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The importance of breast cancer screening has long been known. Unfortunately, there is no imaging modality for screening women with dense breasts that is both sensitive and without concerns regarding potential side effects. The purpose of this study is to explore the possibility of combined diffusion-weighted imaging and turbo inversion recovery magnitude MRI (DWI + TIRM) to overcome the difficulty of detection sensitivity and safety.

Methods

One hundred and seventy-six breast lesions from 166 women with dense breasts were retrospectively evaluated. The lesion visibility, area under the curve (AUC), sensitivity and specificity of cancer detection by MG, DWI + TIRM, and clinical MRI were evaluated and compared. MG plus clinical MRI served as the gold standard for lesion detection and pathology served as the gold standard for cancer detection.

Results

Lesion visibility of DWI + TIRM (96.6%) was significantly superior to MG (67.6%) in women with dense breasts (p < 0.001). There was no significant difference compared with clinical MRI. DWI + TIRM showed higher accuracy (AUC = 0.935) and sensitivity (93.68%) for breast cancer detection than MG (AUC = 0.783, sensitivity = 46.32%), but was comparable to clinical MRI (AUC = 0.944, sensitivity = 93.68%). The specificity of DWI + TIRM (83.95%) was lower than MG (98.77%), but higher than clinical MRI (77.78%).

Conclusions

DWI combined with TIRM could be a safe, sensitive, and practical alternative for screening women with dense breasts.

Sprague BL, Gangnon RE, Burt V, Trentham-Dietz A, Hampton JM, Wellman RD, Kerlikowske K, Miglioretti DL (2014) Prevalence of mammographically dense breasts in the United States. J Natl Cancer Inst. https://doi.org/10.1093/jnci/dju255 CrossRefPubMedPubMedCentral

Liu J, Liu PF, Li JN, Qing C, Ji Y, Hao XS, Zhang XN (2014) Analysis of mammographic breast density in a group of screening chinese women and breast cancer patients. Asian Pac J Cancer Prev: APJCP 15(15):6411–6414CrossRefPubMed

Nelson HD, Zakher B, Cantor A, Fu R, Griffin J, O’Meara ES, Buist DS, Kerlikowske K, van Ravesteyn NT, Trentham-Dietz A et al (2012) Risk factors for breast cancer for women aged 40 to 49 years: a systematic review and meta-analysis. Ann Intern Med 156(9):635–648CrossRefPubMedPubMedCentral

McCormack VA, dos Santos Silva I (2006) Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers & Prev 15(6):1159–1169CrossRef

Kerlikowske K, Ichikawa L, Miglioretti DL, Buist DS, Vacek PM, Smith-Bindman R, Yankaskas B, Carney PA, Ballard-Barbash R (2007) Longitudinal measurement of clinical mammographic breast density to improve estimation of breast cancer risk. J Natl Cancer Inst 99(5):386–395CrossRefPubMed

Welch HG, Prorok PC, O’Malley AJ, Kramer BS (2016) Breast-cancer tumor size, overdiagnosis, and mammography screening effectiveness. N Engl J Med 375(15):1438–1447CrossRefPubMed

Mandelson MT, Oestreicher N, Porter PL, White D, Finder CA, Taplin SH, White E (2000) Breast density as a predictor of mammographic detection: comparison of interval- and screen-detected cancers. J Natl Cancer Inst 92(13):1081–1087CrossRefPubMed

Kolb TM, Lichy J, Newhouse JH (2002) Comparison of the performance of screening mammography, physical examination, and breast US and evaluation of factors that influence them: an analysis of 27,825 patient evaluations. Radiology 225(1):165–175CrossRefPubMed

Melnikow J, Fenton JJ, Whitlock EP, Miglioretti DL, Weyrich MS, Thompson JH, Shah K (2016) Supplemental screening for breast cancer in women with dense breasts: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med 164(4):268–278CrossRefPubMedPubMedCentral

10.

Scheel JR, Lee JM, Sprague BL, Lee CI, Lehman CD (2015) Screening ultrasound as an adjunct to mammography in women with mammographically dense breasts. Am J Obstet Gynecol 212(1):9–17CrossRefPubMed

11.

Geisel J, Raghu M, Hooley R (2018) The role of ultrasound in breast cancer screening: the case for and against ultrasound. Semin Ultrasound CT MR 39(1):25–34CrossRefPubMed

12.

Peairs KS, Choi Y, Stewart RW, Sateia HF (2017) Screening for breast cancer. Semin Oncol 44(1):60–72CrossRefPubMed

13.

Saslow D, Boetes C, Burke W, Harms S, Leach MO, Lehman CD, Morris E, Pisano E, Schnall M, Sener S et al (2007) American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA: Cancer J Clin 57(2):75–89

14.

Warner E, Messersmith H, Causer P, Eisen A, Shumak R, Plewes D (2008) Systematic review: using magnetic resonance imaging to screen women at high risk for breast cancer. Ann Intern Med 148(9):671–679CrossRefPubMed

15.

Beckett KR, Moriarity AK, Langer JM (2015) Safe use of contrast media: what the radiologist needs to know. Radiographics 35(6):1738–1750CrossRefPubMed

16.

Kanda T, Fukusato T, Matsuda M, Toyoda K, Oba H, Kotoku J, Haruyama T, Kitajima K, Furui S (2015) Gadolinium-based contrast agent accumulates in the brain even in subjects without severe renal dysfunction: evaluation of autopsy brain specimens with inductively coupled plasma mass spectroscopy. Radiology 276(1):228–232CrossRefPubMed

17.

Gadolinium-containing contrast agents—European Medicines Agency (2018) European Medicines Agency. https://www.ema.europa.eu/en/medicines/human/referrals/gadolinium-containing-contrast-agents. Accessed 5 Feb 2019

18.

Ramalho M et al (2017) Gadolinium retention and toxicity—an update. Adv Chronic Kidney Dis 24(3):138–146CrossRefPubMed

19.

Malayeri AA, El Khouli RH, Zaheer A, Jacobs MA, Corona-Villalobos CP, Kamel IR, Macura KJ (2011) Principles and applications of diffusion-weighted imaging in cancer detection, staging, and treatment follow-up. Radiographics 31(6):1773–1791CrossRefPubMed

20.

Koh DM, Collins DJ (2007) Diffusion-weighted MRI in the body: applications and challenges in oncology. AJR Am J Roentgenol 188(6):1622–1635CrossRefPubMed

21.

Palle L, Reddy B (2009) Role of diffusion MRI in characterizing benign and malignant breast lesions. Indian J Radiol Imaging 19(4):287–290CrossRefPubMedPubMedCentral

22.

Partridge SC, McDonald ES (2013) Diffusion weighted magnetic resonance imaging of the breast: protocol optimization, interpretation, and clinical applications. Magn Reson Imaging Clin N Am 21(3):601–624CrossRefPubMedPubMedCentral

23.

Guo Y, Cai YQ, Cai ZL, Gao YG, An NY, Ma L, Mahankali S, Gao JH (2002) Differentiation of clinically benign and malignant breast lesions using diffusion-weighted imaging. J Magn Reson Imaging: JMRI 16(2):172–178CrossRefPubMed

24.

Kazama T, Kuroki Y, Kikuchi M, Sato Y, Nagashima T, Miyazawa Y, Sakakibara M, Kaneoya K, Makimoto Y, Hashimoto H et al (2012) Diffusion-weighted MRI as an adjunct to mammography in women under 50 years of age: an initial study. J Magn Reson Imaging: JMRI 36(1):139–144CrossRefPubMed

25.

McDonald ES, Hammersley JA, Chou SH, Rahbar H, Scheel JR, Lee CI, Liu CL, Lehman CD, Partridge SC (2016) Performance of DWI as a rapid unenhanced technique for detecting mammographically occult breast cancer in elevated-risk women with dense breasts. AJR Am J Roentgenol 207(1):205–216CrossRefPubMedPubMedCentral

26.

Hauer MP, Uhl M, Allmann K-H, Laubenberger J, Zimmerhackl LB, Langer M (1998) Comparison of turbo inversion recovery magnitude (TIRM) with T2-weighted turbo spin-echo and T1-weighted spin-echo MR imaging in the early diagnosis of acute osteomyelitis in children. Pediatr Radiol 28(11):846–850CrossRefPubMed

27.

Sadick M, Sadick H, Hormann K, Duber C, Diehl SJ (2005) Diagnostic evaluation of magnetic resonance imaging with turbo inversion recovery sequence in head and neck tumors. Eur Arch Otorhinolaryngol 262(8):634–639CrossRefPubMed

28.

D’Orsi CJ (2013) ACR BI-RADS Atlas: Breast Imaging Reporting and Data System: American College of Radiology

29.

DeLong ER, DeLong DM, Clarke-Pearson DL (1988) Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44(3):837–845CrossRefPubMed

30.

DeSantis CE, Ma J, Goding Sauer A, Newman LA, Jemal A (2017) Breast cancer statistics, 2017, racial disparity in mortality by state. CA Cancer J Clin 67:439–448CrossRefPubMed

31.

Gartlehner G, Thaler K, Chapman A, Kaminski-Hartenthaler A, Berzaczy D, Van Noord MG, Helbich TH (2013) Mammography in combination with breast ultrasonography versus mammography for breast cancer screening in women at average risk. Cochrane Database Syst Rev 4:Cd009632

32.

Iliff JJ et al (2012) A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid. Sci Transl Med 4(147):147ra111CrossRefPubMedPubMedCentral

33.

Tarasoff-Conway JM et al (2015) Clearance systems in the brain—implications for Alzheimer disease. Nat Rev Neurol 11(8):457–470CrossRefPubMedPubMedCentral

34.

Shin HJ, Park JY, Shin KC, Kim HH, Cha JH, Chae EY, Choi WJ (2016) Characterization of tumor and adjacent peritumoral stroma in patients with breast cancer using high-resolution diffusion-weighted imaging: correlation with pathologic biomarkers. Eur J Radiol 85(5):1004–1011CrossRefPubMed

35.

Bogner W, Pinker-Domenig K, Bickel H, Chmelik M, Weber M, Helbich TH, Trattnig S, Gruber S (2012) Readout-segmented echo-planar imaging improves the diagnostic performance of diffusion-weighted MR breast examinations at 3.0 T. Radiology 263(1):64–76CrossRefPubMed

36.

Barentsz MW, Taviani V, Chang JM, Ikeda DM, Miyake KK, Banerjee S, van den Bosch MA, Hargreaves BA, Daniel BL (2015) Assessment of tumor morphology on diffusion-weighted (DWI) breast MRI: diagnostic value of reduced field of view DWI. J Magn Reson Imaging: JMRI 42(6):1656–1665CrossRefPubMed

37.

van de Bank BL et al (2012) Ultra high spatial and temporal resolution breast imaging at 7T. NMR Biomed 26(4):367–375CrossRefPubMed

38.

Springer E et al (2016) Comparison of routine brain imaging at 3T and 7T. Invest Radiol 51(8):469–482CrossRefPubMedPubMedCentral

39.

Baltzer PA, Benndorf M, Dietzel M, Gajda M, Camara O, Kaiser WA (2010) Sensitivity and specificity of unenhanced MR mammography (DWI combined with T2-weighted TSE imaging, ueMRM) for the differentiation of mass lesions. Eur Radiol 20(5):1101–1110CrossRefPubMed

40.

Bickelhaupt S, Tesdorff J, Laun FB, Kuder TA, Lederer W, Teiner S, Maier-Hein K, Daniel H, Stieber A, Delorme S et al (2017) Independent value of image fusion in unenhanced breast MRI using diffusion-weighted and morphological T2-weighted images for lesion characterization in patients with recently detected BI-RADS 4/5 x-ray mammography findings. Eur Radiol 27(2):562–569CrossRefPubMed

41.

Lehman CD (2006) Role of MRI in screening women at high risk for breast cancer. J Magn Reson Imaging 24(5):964–970CrossRefPubMed

42.

Lehman CD, Blume JD, Weatherall P et al (2005) Screening women at high risk for breast cancer with mammography and magnetic resonance imaging. Cancer 103:1898–1905CrossRefPubMed

43.

Podo F, Sardanelli F, Canese R et al (2002) The Italian multi-centre project on evaluation of MRI and other imaging modalities in early detection of breast cancer in subjects at high genetic risk. J Exp Clin Cancer Res 21:115–124PubMed

44.

Tilanus-Linthorst MM, Obdeijn IM, Bartels KC, de Koning HJ, Oudkerk M (2000) First experiences in screening women at high risk for breast cancer with MR imaging. Breast Cancer Res Treat 63:53–60CrossRefPubMed

45.

Morris EA, Liberman L, Ballon DJ et al (2003) MRI of occult breast carcinoma in a high-risk population. AJR Am J Roentgenol 181:619–626CrossRefPubMed

46.

Yabuuchi H, Matsuo Y, Sunami S, Kamitani T, Kawanami S, Setoguchi T, Sakai S, Hatakenaka M, Kubo M, Tokunaga E et al (2011) Detection of non-palpable breast cancer in asymptomatic women by using unenhanced diffusion-weighted and T2-weighted MR imaging: comparison with mammography and dynamic contrast-enhanced MR imaging. Eur Radiol 21(1):11–17CrossRefPubMed

47.

Kuhl CK, Schrading S, Leutner CC et al (2005) Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer. J Clin Oncol 23:8469–8476CrossRefPubMed

48.

Warner E, Plewes DB, Shumak RS, Catzavelos GC, Di Prospero LS, Yaffe MJ, Goel V, Ramsay E, Chart PL, Cole DEC, Taylor GA, Cutrara M, Samuels TH, Murphy JP, Murphy JM, Narod SA (2001) Comparison of breast magnetic resonance imaging, mammography, and ultrasound for surveillance of women at high risk for hereditary breast cancer. J Clin Oncol 19(15):3524–3531CrossRefPubMed

49.

Kuhl CK, Schrading S, Strobel K, Schild HH, Hilgers R-D, Bieling HB (2014) Abbreviated breast magnetic resonance imaging (MRI): first postcontrast subtracted images and maximum-intensity projection—a novel approach to breast cancer screening with MRI. J Clin Oncol 32(22):2304–2310CrossRefPubMed

50.

Fan L, Strasserweippl K, Li JJ et al (2014) Breast cancer in China. Lancet Oncol 15(7):e279–e289CrossRefPubMed

51.

Li H, Zheng R, Zhang S et al (2018) Incidence and mortality of female breast cancer in China, 2014. Chin J Cancer 40(3):166–171

52.

Kriege M, Brekelmans CT, Boetes C et al (2004) Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. N Engl J Med 351:427–437CrossRefPubMed

53.

Phi XA, Tagliafico A, Houssami N et al (2018) Digital breast tomosynthesis for breast cancer screening and diagnosis in women with dense breasts—a systematic review and meta-analysis. BMC Cancer 18(1):380CrossRefPubMedPubMedCentral

54.

Skaane P, Bandos AI, Gullien R et al (2013) Comparison of digital mammography alone and digital mammography plus tomosynthesis in a population-based screening program. Radiology 267(1):47–56CrossRefPubMed

55.

Gur D, Abrams GS, Chough DM et al (2009) Digital breast tomosynthesis: observer performance study. AJR Am J Roentgenol 193(2):586–591CrossRefPubMed

56.

Roganovic D, Djilas D, Vujnovic S et al (2015) Breast MRI, digital mammography and breast tomosynthesis: comparison of three methods for early detection of breast cancer. Bosn J Basic Med Sci 15(4):64–68. https://doi.org/10.17305/bjbms.2015.616 CrossRefPubMedPubMedCentral

57.

Förnvik D, Kataoka M, Iima M, Ohashi A, Kanao S, Toi M, Togashi K (2018) The role of breast tomosynthesis in a predominantly dense breast population at a tertiary breast centre: breast density assessment and diagnostic performance in comparison with MRI. Eur Radiol 28(8):3194–3203. https://doi.org/10.1007/s00330-017-5297-7 CrossRefPubMedPubMedCentral

Titel: Non-contrast MRI for breast screening: preliminary study on detectability of benign and malignant lesions in women with dense breasts
verfasst von: Yangyang Bu
Jun Xia
Bobby Joseph
Xianjing Zhao
Maosheng Xu
Yingxing Yu
Shouliang Qi
Kamran A. Shah
Shiwei Wang
Jiani Hu
Publikationsdatum: 19.07.2019
Verlag: Springer US
Erschienen in: Breast Cancer Research and Treatment / Ausgabe 3/2019
Print ISSN: 0167-6806
Elektronische ISSN: 1573-7217
DOI: https://doi.org/10.1007/s10549-019-05342-5

Springer Medizin

Non-contrast MRI for breast screening: preliminary study on detectability of benign and malignant lesions in women with dense breasts